Literature DB >> 22265807

Abandoning unilateral parathyroidectomy: why we reversed our position after 15,000 parathyroid operations.

James Norman1, Jose Lopez, Douglas Politz.   

Abstract

BACKGROUND: Our group championed the techniques and benefits of unilateral parathyroidectomy. As our experience has matured, it seems this limited operation might be appropriate only occasionally.
METHODS: A single surgical group's experience with 15,000 parathyroidectomies examined the ongoing differences between unilateral and bilateral techniques for 10-year failure/recurrence, multigland removal, operative times, and length of stay.
RESULTS: With limited experience, 100% of operations were bilateral, decreasing to 32% by the 500(th) operation (p < 0.001), and long-term failure rates increased to 6%. Failures were 11 times more likely for unilateral explorations (p < 0.001 vs bilateral), causing gradual increases in bilateral explorations to 97% at the 14,000(th) operation (p < 0.001). Ten-year cure rates are unchanged for bilateral operations, and unilateral operations show continued slow recurrence rates of 5% (p < 0.001). Removal of more than one gland occurred 16 times more frequently when 4 glands were analyzed (p < 0.001), increasing cure rates to the current 99.4% (p < 0.001). Of 1,060 reoperations performed for failure at another institution, intraoperative parathyroid hormone levels fell >50% in 22% of patients, yet a second adenoma was subsequently found. Operative times decreased with experience; bilateral operations taking only 5.9 minutes longer on average (22.3 vs 16.4 minutes; p < 0.001), which is 25 minutes less than unilateral at the 500(th) operation (p < 0.001). By the 1,000(th) operation, incision size (2.5 ± 0.2 cm), anesthesia, and hospital stay (1.6 hours) were identical for unilateral and bilateral procedures.
CONCLUSIONS: Regardless of surgical adjuncts (scanning, intraoperative parathyroid hormone), unilateral parathyroidectomy will carry a 1-year failure rate of 3% to 5% and a 10-year recurrence rate of 4% to 6%. Allowing rapid analysis of all 4 glands through the same 1-inch incision has caused us to all but abandon unilateral parathyroidectomy. Copyright Â
© 2012 American College of Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22265807     DOI: 10.1016/j.jamcollsurg.2011.12.007

Source DB:  PubMed          Journal:  J Am Coll Surg        ISSN: 1072-7515            Impact factor:   6.113


  34 in total

1.  Risk factors for treatment failure in surgery for primary hyperparathyroidism: the impact of change in surgical strategy and training procedures.

Authors:  Anders Rørbæk Madsen; Lars Rasmussen; Christian Godballe
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-06-05       Impact factor: 2.503

2.  Surgical cure of primary hyperparathyroidism ameliorates gastroesophageal reflux symptoms.

Authors:  James Norman; Douglas Politz; Jose Lopez; Deva Boone; Alexander Stojadinovic
Journal:  World J Surg       Date:  2015-03       Impact factor: 3.352

3.  What Should We Tell Our Patients? Lifetime Guarantee or is it 5- to 10-year Warranty on a Parathyroidectomy for Primary Hyperparathyroidism?

Authors:  Janice L Pasieka
Journal:  World J Surg       Date:  2015-08       Impact factor: 3.352

Review 4.  Updates in primary hyperparathyroidism.

Authors:  Guido Gasparri
Journal:  Updates Surg       Date:  2017-06-23

5.  Minimally invasive parathyroid surgery.

Authors:  Randall P Owen; Carl E Silver; Ashok R Shaha; Phillip K Pellitteri; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-01-31       Impact factor: 2.503

6.  How long should we follow patients after apparently curative parathyroidectomy?

Authors:  Irene Lou; Courtney Balentine; Samuel Clarkson; David F Schneider; Rebecca S Sippel; Herbert Chen
Journal:  Surgery       Date:  2016-11-15       Impact factor: 3.982

7.  Is minimally invasive parathyroidectomy associated with greater recurrence compared to bilateral exploration? Analysis of more than 1,000 cases.

Authors:  David F Schneider; Haggi Mazeh; Rebecca S Sippel; Herbert Chen
Journal:  Surgery       Date:  2012-10-12       Impact factor: 3.982

8.  Use of the gamma probe to identify multigland disease in primary hyperparathyroidism.

Authors:  Kirby Tobin; Rachel R Ayers; Mohammad Rajaei; Rebecca S Sippel; Courtney J Balentine; Dawn Elfenbein; Herb Chen; David F Schneider
Journal:  Int J Endocr Oncol       Date:  2016-02

9.  Perioperative management difficulties in parathyroidectomy for primary versus secondary and tertiary hyperparathyroidism.

Authors:  Marioara Corneci; Bogdan Stanescu; Raluca Trifanescu; Elena Neacsu; Dan Corneci; Catalina Poiana; Teodor Horvat
Journal:  Maedica (Buchar)       Date:  2012-06

10.  Predictors of recurrence in primary hyperparathyroidism: an analysis of 1386 cases.

Authors:  David F Schneider; Haggi Mazeh; Herbert Chen; Rebecca S Sippel
Journal:  Ann Surg       Date:  2014-03       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.